Innovations in Addressing Pediatric Diarrhea in Low Resource Settings
Rajiv S Jumani1, Jonathan M Spector1, Rasa Izadnegahdar2
1Novartis Institute for Tropical Diseases , 5300 Chiron Way , Emeryville , California 94608 , United States.
Abstract:
Diarrhea has long been recognized as an important cause of mortality during childhood. In parallel with ensuring access to proven care practices is the imperative to apply modern advances in medicine, science, and technology to accelerate progress against diarrheal disease, particularly in developing countries where the burden of avoidable harm is the greatest. In order to highlight achievements and identify outstanding areas of need, we reviewed the landscape of recent innovations that have significance for the study and clinical management of pediatric diarrhea in low resource settings.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drug Dosing: Infants and Children


